✦ LIBER ✦

Estrogen receptor β– an independent prognostic marker in estrogen receptor α and progesterone receptor-positive breast cancer?

✍ Scribed by BJØRN O. MÆHLE; KARIN COLLETT; STEINAR TRETLI; LARS A. AKSLEN; TOM GROTMOL

Book ID: 109343947
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 135 KB
Volume: 117
Category: Article
ISSN: 0365-5555
DOI: 10.1111/j.1600-0463.2009.02510.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogen receptor α-negative and progest

Estrogen receptor α-negative and progesterone receptor-positive breast cancer: Lab error or real entity?

✍ Jawad Kiani; Afrasyab Khan; Hina Khawar; Fawad Shuaib; Shahid Pervez 📂 Article 📅 2006 🏛 Springer Netherlands 🌐 English ⚖ 289 KB

Estrogen and Progesterone Receptors in P

Estrogen and Progesterone Receptors in Primary Breast Cancer

✍ Sue A. Joslyn; Dean H. Gesme Jr.; Charles F. Lynch 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 995 KB

Prognostic value of estrogen and progest

Prognostic value of estrogen and progesterone receptors in primary breast cancer

✍ Simone Saez; Françoise Cheix; Bernard Asselain 📂 Article 📅 1983 🏛 Springer US 🌐 English ⚖ 760 KB

Estrogen Receptor Mutations and Changes

Estrogen Receptor Mutations and Changes in Estrogen Receptor and Progesterone Receptor Protein Expression in Metastatic or Recurrent Breast Cancer

✍ Umekita, Yoshihisa ;Sagara, Yoshiatsu ;Yoshida, Hiroki 📂 Article 📅 1998 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 159 KB

Estrogen receptor: A prognostic factor i

Estrogen receptor: A prognostic factor in breast cancer

✍ Naguib A. Samaan; Aman U. Buzdar; Keith A. Aldinger; Pamela N. Schultz; Kuo-Pao 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB 👁 2 views

Prognostic significance of estrogen and

Prognostic significance of estrogen and progesterone receptors in stage ii breast cancer

✍ Stefan Rydén; Mårten Fernö; Åke Borg; Larsolof Hafström; Torgil Möller; Allan No 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Estrogen (ER) and progesterone receptors (PgR) were evaluated in samples from primary tumors in 539 patients with stage I1 breast cancer participating in a randomized multicenter controlled clinical trial on adjuvant therapy. At the cut-off points of 10 fmol EWmg protein and 30 fmol PgR/ mg protein,